Hispanic patients with Merkel cell carcinoma have lower mortality compared to non-Hispanic patients in the National Cancer Database - 19/09/24
Doi : 10.1016/j.jaad.2024.05.089
Winston W. Liu, MD, PhD a, Olivia S. Jew, MD, MBA a, Kristen E. Rhodin, MD, MHS b, Jay S. Lee, MD b, c, Georgia M. Beasley, MD, MHS b, d, Melodi Javid Whitley, MD, PhD a, ⁎ 
a Department of Dermatology, Duke University School of Medicine, Durham, North Carolina
b Department of Surgery, Duke University School of Medicine, Durham, North Carolina
c Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina
d Department of Medicine, Duke University School of Medicine, Durham, North Carolina
∗Correspondence to: Melodi Javid Whitley, MD, PhD, Department of Dermatology, Duke University School of Medicine, Box 3515, 40 Duke Medicine Circle, Durham, NC 27710Department of DermatologyDuke University School of MedicineBox 3515, 40 Duke Medicine CircleDurhamNC27710
Key words : health disparities, Latinx, Merkel cell carcinoma, outcomes, skin of color
| Funding sources: Dr Liu is supported by NIH F30 DK122712. |
|
| This work was previously presented at the 2023 ASDS, Chicago, IL, November 4, 2023. |
|
| Patient consent: Not applicable. |
|
| IRB approval status: This study was deemed exempt by the Duke University Health System Institutional Review Board. |
© 2024
American Academy of Dermatology, Inc. Tous droits réservés.
Vol 91 - N° 4
P. 750-753 - octobre 2024 Retour au numéro
Article précédent
- Pemphigoid gestationis is associated with an increased risk for adverse pregnancy outcomes: A large-scale propensity-matched retrospective cohort study
- Sophie L. Preuß, Artem Vorobyev, Eva Lotta Moderegger, Patrick Terheyden, Katja Bieber, Khalaf Kridin, Pascal Joly, Ralf J. Ludwig
- Characterization of adverse cutaneous effects in the setting of enfortumab vedotin for metastatic urothelial carcinoma: A retrospective review
- Rhea Malik, David H. Xiang, Grant J. Riew, Stephanie Sanchez-Melendez, Shawn Afvari, Nicole R. LeBoeuf, Vinod E. Nambudiri
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?